Search results
Results from the WOW.Com Content Network
APON/BPON, EPON and GPON have been widely deployed. In November 2014, EPON had approximately 40 million deployed ports and ranks first in deployments. [47] As of 2015, GPON had a smaller market share, but is anticipated to reach $10.5 billion US dollars by 2020. [48] For TDM-PON, a passive optical splitter is used in the optical distribution ...
The adverse effects of TTFields include local skin rashes and irritation caused by prolonged electrode use. [13] [7] [6] Compared with other cancer treatment methods, this effect is very minimal and tolerable for the patient. [13] This irritation can be controlled with steroid creams and periodic breaks from treatment. [7]
Etoposide, sold under the brand name Vepesid among others, is a chemotherapy medication used for the treatments of a number of types of cancer including testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer. [2] It is also used for hemophagocytic lymphohistiocytosis. [3] It is used by mouth or injection into a ...
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
The GPON OMCI recommendation G.984.4 draws on G.983.2, which defines the BPON management model. However, G.984.4 removed all references to ATM. G.988 is a stand-alone OMCI recommendation and supersedes G.984.4 except for GPON specifics that are not defined in G.988. Future work on the PON management model is expected to appear only in the GPON ...
This compares to the IEEE 802.3av standard for 10G-EPON based on Ethernet, which has standardised upstream rates of both 1 Gbit/s and 10 Gbit/s. [8] The 10 gigabit PON wavelengths (1577 nm down / 1270 nm up) differ from GPON and EPON (1490 nm down /1310 nm up), allowing it to coexist on the same fibre with either of the gigabit PONs. [9]
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
Electrochemotherapy (ECT [1]) is a type of chemotherapy that allows delivery of non-permeant drugs to the cell interior. It is based on the local application of short and intense electric pulses that transiently permeabilize the cell membrane, thus allowing transport of molecules otherwise not permitted by the membrane.